Atropine is synthesized by reducing phenylalanine. Atropine is used as a medication to treat conditions such as pesticide poisoning and nerve agents. It is mainly utilized during surgeries if the heart rate falls suddenly to anaerobic levels or the patient experiences reduced salivary secretions resulting in dry mouth. It is required in high dosages if the patient is antibiotic-resistant. Atropine in high amounts can cause drowsiness, convulsions, coma, and stupor.

The atropine market is divided into small segments globally with only a few countries producing it while the others procuring it. The atropine market is oligopolistic in nature. Countries such as the US and China are the leaders in global atropine production. Both the US and China combined are responsible for 67%-69% of the global atropine supply.

Due to the low cost of production, less profit margin, and a relatively leaner demand, the global atropine market experienced negative growth between 2013 and 2017. This led to a shortage of atropine supply globally. Many companies shut down the production of atropine due to losses.

The C2 PHARMA is the leading manufacturer of atropine accounting for approximately 10% of the total market share.

Key Factors Impacting Market Growth:

  • Increasing demand in the Asian market
  • Decreasing demand in the Western European market
  • Falling demand due to lethal side effects

What Does This Report Provide?

This report provides a detailed understanding of the global atropine market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Type:

  • Injection
  • Drop
  • Gel

By Application:

  • Gastrointestinal
  • Ophthalmology
  • Neurology
  • Nephrology
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Type
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type
    • By Application
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Type
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Type
    • By Application

Companies Covered: C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng Group, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, and Wuhan Senwayer Century

 Reasons to Buy This Report:

  • Market size estimation of the global atropine market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offerings

Single User License - USD 3999

Multi User License - USD 5499

Corporate License - USD 6999

Why QMI?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

Close Menu